Evaluating adherence to ESC guidelines for Chronic Coronary Syndrome
Official title: Chronic Coronary Syndrome Snapshot Study
Run by European Society of Cardiology · NCT06748924 · Data updated 2026-11-12
This study looks at how well doctors are following the latest guidelines for treating chronic coronary syndrome in adults to see what helps or hinders their care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 4000 (estimated) |
| Sponsor | European Society of Cardiology Research network |
| Locations | 1 site (Yerevan) |
| Status | Recruiting |
| Started | December 2, 2024 |
| Main results expected | June 2, 2025 |
| Study ends | June 2, 2025 |
| Registry record updated | January 9, 2025 |
| Trial ID | NCT06748924 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults with suspected coronary artery disease, new onset heart failure, or those within one year after an acute coronary syndrome.
✕Probably not a fit
Patients with a recent acute coronary syndrome or those with unrelated conditions that limit participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess how well healthcare professionals follow the 2019 European Society of Cardiology (ESC) Guidelines on Chronic Coronary Syndrome (CCS). It will evaluate adherence across various healthcare settings and identify barriers and facilitators to implementing these guidelines. The study will enroll adult patients with confirmed or suspected CCS to gather data on current practices and outcomes. The findings will help inform targeted interventions to improve guideline adherence and patient care.
Why it matters
Potential benefit: If successful, this study could enhance the quality of care for patients with Chronic Coronary Syndrome by improving adherence to established guidelines.
How similar studies have gone: Other studies have shown success in evaluating guideline adherence, making this approach both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with angina and/or dyspnoea, and suspected coronary artery disease. * Patients with new onset of heart failure or reduced left ventricular function. * Patients within 1 year after an acute coronary syndrome or recent revascularisation. * Patients beyond 1 year after initial diagnosis or revascularisation. * Patients with Angina with No Obstructive Coronary Artery disease (ANOCA)(e.g., microvascular angina, vasospastic angina). * Asymptomatic subjects referred for screening for coronary artery disease. Exclusion Criteria: * Patients with a recent acute coronary syndrome (defined as those within 1 month of a diagnosis of unstable angina, non-ST-segment elevation myocardial infarction or ST-segment elevation myocardial infarction). * Patients with conditions unrelated to CCS that significantly limit their ability to participate in the study or interfere with the assessment of guideline adherence. * Patients participating in any clinical study where the protocol recommends deviations from guidelines recommendations.
Where it's running
-
Erebouni Medical Center
Yerevan, Armenia Recruiting
Study contacts
- Study coordinator: Emilie Head of Department
- Email: registries@escardio.org
- Phone: +33489872018
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Common femoral vein-to-artery diameter ratio to detect elevated LVEDP
Researchers test whether the ratio of the common femoral vein to artery diameters, measured by ultrasound, can flag elevated LV end-diastolic pressure in patients having coronary angiography.
-
Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI
This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
IVUS-Guided Left Main Stenting: IVUS-Guided vs Trained-Eye Approach
This trial tests whether using IVUS to guide left main bifurcation stenting is as good as using an angiography-driven, experience-based approach by an IVUS-savvy operator.
-
Can CZT-SPECT/CT quantify myocardial tracer uptake to match PET measurements in coronary artery disease?
This study tests whether CZT-SPECT/CT can quantify heart blood flow at rest and stress and see if the results align with PET measurements for people with coronary artery disease.
-
Ultrasound vs CT calcium scoring to reclassify symptomatic chest pain
This study tests whether carotid ultrasound can reclassify risk in adults with chest pain and suspected chronic coronary syndrome, compared with the CT calcium score.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.